Evidence map›Paper›PMID 28885613›Full record

ArticleBlood cancer journal2017

MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia.

T Zhang, J K Davidson-Moncada, P Mukherjee, R R Furman, E Bhavsar, Z Chen, P Hakimpour, N Papavasiliou, W Tam

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. The Features of Immune Checkpoint Gene Regulation by microRNA in Cancer.International journal of molecular sciences · 2022
    Review
  2. Targeting Casein Kinase 1 (CK1) in Hematological Cancers.International journal of molecular sciences · 2020
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

T ZhangDivision of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
J K Davidson-MoncadaDivision of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
P MukherjeeEpigenomics Core Facility, Weill Cornell Medicine, New York, NY, USA.
R R FurmanDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
E BhavsarDivision of Hematology and Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Z ChenDepartment of Healthcare Policy &Research, Weill Cornell Medicine, New York, NY, USA.
P HakimpourLaboratory of Lymphocyte Biology, The Rockefeller University, New York, NY, USA.
N PapavasiliouLaboratory of Lymphocyte Biology, The Rockefeller University, New York, NY, USA.
W TamDivision of Hematopathology, Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
Cornell University · USRockefeller University · USWeill Cornell Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Casein Kinase IHumansLeukemia, Lymphocytic, Chronic, B-CellMicroRNAsNeoplasm ProteinsRNA, NeoplasmCasein Kinase IMicroRNAsMIRN155 microRNA, humanNeoplasm ProteinsRNA, Neoplasm

Identifiers

PMID28885613
PMCPMC5709749
OpenAlexW2752685518

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.